S&P 500   3,360.47 (+0.27%)
DOW   27,791.44 (+1.30%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
S&P 500   3,360.47 (+0.27%)
DOW   27,791.44 (+1.30%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
S&P 500   3,360.47 (+0.27%)
DOW   27,791.44 (+1.30%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
S&P 500   3,360.47 (+0.27%)
DOW   27,791.44 (+1.30%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
Log in

NASDAQ:SYNSynthetic Biologics News Headlines

$0.58
-0.01 (-1.02 %)
(As of 08/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.57
Now: $0.58
$0.59
50-Day Range
$0.49
MA: $0.54
$0.71
52-Week Range
$0.25
Now: $0.58
$0.75
Volume289,202 shs
Average Volume435,869 shs
Market Capitalization$11.29 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Synthetic Biologics (NASDAQ SYN) News Headlines

Source:
DateHeadline
Synthetic Biologics (SYN) CEO Steven Shallcross on Q2 2020 Results - Earnings Call TranscriptSynthetic Biologics' (SYN) CEO Steven Shallcross on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 6 at 11:06 PM
Synthetic Biologics (SYN) Scheduled to Post Earnings on ThursdaySynthetic Biologics (SYN) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - August 2 at 10:29 AM
Synthetic Biologics on go with first study of enzyme therapy for gut healthSynthetic Biologics on go with first study of enzyme therapy for gut health
seekingalpha.com - July 30 at 11:19 AM
Synthetic Biologics (NASDAQ:SYN) Trading 1.8% Higher Synthetic Biologics (NASDAQ:SYN) Trading 1.8% Higher
www.americanbankingnews.com - July 28 at 1:59 AM
Protein A-Resins Market Witnessing Investment Exodus From Biopharmaceutical Manufacturers: Future Market Insights ReportProtein A-Resins Market Witnessing Investment Exodus From Biopharmaceutical Manufacturers: Future Market Insights Report
www.prnewswire.com - July 13 at 12:27 PM
IBS Treatment Market Share 2020 – Global Growth, Trends, Industry Analysis, Key Players and Forecast 2020 – 2023IBS Treatment Market Share 2020 – Global Growth, Trends, Industry Analysis, Key Players and Forecast 2020 – 2023
www.marketwatch.com - July 9 at 8:15 AM
Synthetic Bio inks deal to advance development of candidate SYN-020Synthetic Bio inks deal to advance development of candidate SYN-020
seekingalpha.com - May 27 at 9:52 AM
BRIEF-Synthetic Biologics Enters Option To License Intellectual Property For Use Of SYN-020 For Age-Related Metabolic, Inflammatory DiseasesBRIEF-Synthetic Biologics Enters Option To License Intellectual Property For Use Of SYN-020 For Age-Related Metabolic, Inflammatory Diseases
www.reuters.com - May 27 at 9:52 AM
How Synthetic Biologics, Inc. (NYSEMKT:SYN) Can Impact Your Portfolio VolatilityHow Synthetic Biologics, Inc. (NYSEMKT:SYN) Can Impact Your Portfolio Volatility
finance.yahoo.com - May 6 at 11:12 AM
Synthetic Biologics EPS beats by $0.07Synthetic Biologics EPS beats by $0.07
seekingalpha.com - May 5 at 5:11 PM
Synthetic Biologics Reports 2020 First Quarter Operational Highlights and Financial ResultsSynthetic Biologics Reports 2020 First Quarter Operational Highlights and Financial Results
finance.yahoo.com - May 5 at 5:11 PM
KICVentures Appoints Jake Lubinski as CEO of NanoFUSE BiologicsKICVentures Appoints Jake Lubinski as CEO of NanoFUSE Biologics
www.benzinga.com - March 19 at 12:48 PM
Synthetic Biologics, Inc. (SYN) CEO Steven Shallcross on Q4 2019 Results - Earnings Call TranscriptSynthetic Biologics, Inc. (SYN) CEO Steven Shallcross on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - February 20 at 10:56 PM
Synthetic Biologics Reports 2019 Year End Operational Highlights and Financial ResultsSynthetic Biologics Reports 2019 Year End Operational Highlights and Financial Results
finance.yahoo.com - February 20 at 5:56 PM
Microbiome Therapeutics Market Share 2020 In-Depth Analysis of Industry Growth Trends & Forecast up to 2026Microbiome Therapeutics Market Share 2020 In-Depth Analysis of Industry Growth Trends & Forecast up to 2026
www.marketwatch.com - January 24 at 7:06 AM
Tissue Engineered Skin Substitute Market - Global Industry Analysis and Opportunity Assessment, 2019-2029Tissue Engineered Skin Substitute Market - Global Industry Analysis and Opportunity Assessment, 2019-2029
www.marketwatch.com - January 18 at 6:18 PM
Microbiome Therapeutics Market to Witness Growth in Inflammatory Bowel Disorder Segment, says Fortune Business InsightsMicrobiome Therapeutics Market to Witness Growth in Inflammatory Bowel Disorder Segment, says Fortune Business Insights
www.marketwatch.com - January 7 at 6:43 AM
Edited Transcript of SYN earnings conference call or presentation 4-Nov-19 9:30pm GMTEdited Transcript of SYN earnings conference call or presentation 4-Nov-19 9:30pm GMT
finance.yahoo.com - November 8 at 3:22 PM
Synthetic Biologics, Inc. (SYN) CEO Steven Shallcross on Q3 2019 Results - Earnings Call TranscriptSynthetic Biologics, Inc. (SYN) CEO Steven Shallcross on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 4 at 8:58 PM
Synthetic Biologics Reports Third Quarter 2019 Operational Highlights and Financial ResultsSynthetic Biologics Reports Third Quarter 2019 Operational Highlights and Financial Results
finance.yahoo.com - November 4 at 4:28 PM
Synthetic Biologics to Report 2019 Third Quarter Operational Highlights and Financial Results on November 4, 2019Synthetic Biologics to Report 2019 Third Quarter Operational Highlights and Financial Results on November 4, 2019
finance.yahoo.com - October 28 at 4:46 PM
Synthetic Biologics Strengthens U.S. Patent Coverage of SYN-010, Intended for the Novel Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)Synthetic Biologics Strengthens U.S. Patent Coverage of SYN-010, Intended for the Novel Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)
finance.yahoo.com - September 26 at 9:34 AM
Synthetic Biology Market demand is expected to increase at a robust CAGR of 33.2% through to 2025.Synthetic Biology Market demand is expected to increase at a robust CAGR of 33.2% through to 2025.
www.marketwatch.com - September 12 at 10:33 AM
Cell Line Development Market Share, Size to witness high growth in near futureCell Line Development Market Share, Size to witness high growth in near future
www.marketwatch.com - September 10 at 4:59 PM
Does The Synthetic Biologics, Inc. (NYSEMKT:SYN) Share Price Tend To Follow The Market?Does The Synthetic Biologics, Inc. (NYSEMKT:SYN) Share Price Tend To Follow The Market?
finance.yahoo.com - September 6 at 2:59 PM
Sýn hf.: Financial results below expectations but positive outlookSýn hf.: Financial results below expectations but positive outlook
finance.yahoo.com - August 28 at 4:49 PM
Sýn hf.: Change in guidanceSýn hf.: Change in guidance
finance.yahoo.com - August 20 at 9:56 AM
Edited Transcript of SYN earnings conference call or presentation 8-Aug-19 8:30pm GMTEdited Transcript of SYN earnings conference call or presentation 8-Aug-19 8:30pm GMT
finance.yahoo.com - August 9 at 4:08 PM
Synthetic Biologics Reports Second Quarter 2019 Operational Highlights and Financial ResultsSynthetic Biologics Reports Second Quarter 2019 Operational Highlights and Financial Results
finance.yahoo.com - August 8 at 9:13 PM
Synthetic Biologics to Report 2019 Second Quarter Operational Highlights and Financial Results on August 8, 2019Synthetic Biologics to Report 2019 Second Quarter Operational Highlights and Financial Results on August 8, 2019
finance.yahoo.com - August 1 at 9:56 AM
Those Who Purchased Synthetic Biologics (NYSEMKT:SYN) Shares Three Years Ago Have A 99% Loss To Show For ItThose Who Purchased Synthetic Biologics (NYSEMKT:SYN) Shares Three Years Ago Have A 99% Loss To Show For It
finance.yahoo.com - May 27 at 4:01 PM
Sýn hf.: Notification of related party tradingSýn hf.: Notification of related party trading
finance.yahoo.com - May 24 at 11:44 AM
Edited Transcript of SYN earnings conference call or presentation 27-Feb-19 9:30pm GMTEdited Transcript of SYN earnings conference call or presentation 27-Feb-19 9:30pm GMT
finance.yahoo.com - February 28 at 3:55 PM
Synthetic Biologics Reports 2018 Year End Operational Highlights and Financial ResultsSynthetic Biologics Reports 2018 Year End Operational Highlights and Financial Results
www.prnewswire.com - February 27 at 4:18 PM
Sýn hf. : Merged company completes its first full year under challenging market conditionsSýn hf. : Merged company completes its first full year under challenging market conditions
finance.yahoo.com - February 27 at 3:55 PM
Sýn hf. : Changes in management of Sýn hf.Sýn hf. : Changes in management of Sýn hf.
finance.yahoo.com - February 27 at 3:55 PM
Sýn hf. : Q4 Investors presentationSýn hf. : Q4 Investors presentation
finance.yahoo.com - February 27 at 3:55 PM
This page was last updated on 8/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.